Conversion in denture base polymers.

I E Ruyter; H Oysaed

doi:10.1002/jbm.820160520

Home/Archive/PubMed

PubMed · 7130224

Conversion in denture base polymers.

I E Ruyter·H Oysaed

View original source ↗Export metadata ↓

Abstract

The purpose of this investigation was to determine residual monomers, the insoluble gel fraction, and singly reacted dimethacrylate monomers in heat-polymerized, auto-polymerized conventional and pour-type denture base materials. Residual monomers were determined by HPLC analysis of tetrahydrofuran extracts of denture base polymers. The gel fraction was determined by gravimetric analysis of the nonextractable portion. The pendant methacrylate groups in the gel fraction were determined by quantitative IR (infrared) spectrometry. It was demonstrated that the heat-polymerized materials had the lowest content of residual monomers. Generally, the content of pendant methacrylate groups in the gel was dependent on the initial quantity of crosslinking agent in the monomer liquids. The gel fractions of the heat-polymerized materials were larger than the quantity of reacted monomers and were also dependent on the quantity of crosslinking agent. These findings showed that some of the linear prepolymer, poly(methyl methacrylate) (PMMA), had been incorporated into the crosslinked polymer system. The gel fraction of the auto-polymerized pour-type materials corresponded to the quantity of reacted monomers, whereas the conventional auto-polymerized materials took an intermediate position between pour type materials and heat-polymerized materials in this respect.

Explore related subjects

Acrylates Chromatography, High Pressure Liquid Cross-Linking Reagents Dental Materials Gels Methacrylates Methylmethacrylate Methylmethacrylates Polymers Pressure Quality Control Spectrophotometry, Infrared Temperature Comparative Study Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

I E Ruyter, H Oysaed. 1982. Conversion in denture base polymers.. https://doi.org/10.1002/jbm.820160520

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

The tryptophan synthase alpha 2 beta 2 complex: kinetic studies with a mutant enzyme (beta K87T) to provide evidence for allosteric activation by an aminoacrylate intermediate.

To investigate the mechanism by which the tryptophan synthase beta subunit accelerates the cleavage of the indole-3-glycerol phosphate catalyzed by the alpha subunit (alpha reaction), kinetic experiments were carried out with wild-type and mutant forms of the alpha 2 beta 2 complex. Previous studies indicate that this activation can be attributed to the conformational changes associated with the formation of a Schiff base between aminoacrylate and pyridoxal phosphate at the beta site. To test this hypothesis, we investigated a mutant form of the alpha 2 beta 2 complex having the lysine-87 of its beta subunits replaced by threonine. The mutant alpha 2 beta 2 complex (K87T) exhibits normal activity for the alpha reaction but fails to catalyze formation of L-tryptophan from L-serine and indole (beta reaction). However, the mutant enzyme can form a Schiff base intermediate with L-serine at the beta site. Using a "chemical rescue" method, we converted K87T L-serine intermediate to an aminoacrylate intermediate. Steady-state kinetic studies reveal that the aminoacrylate derivative exhibits a 7-fold enhancement in kcat/Km for the alpha reaction relative to that of the L-serine derivative of the mutant or the wild-type enzyme in the absence of L-serine. Rapid kinetic data show that the aminoacrylate derivative of the mutant enzyme exhibits a 6-fold increase in the rate constant for the indole-3-glycerol phosphate cleavage reaction. In addition, rate constants for the reverse reaction and product release steps are also altered. Together, these changes lead to a decrease in Km and an increase in kcat.(ABSTRACT TRUNCATED AT 250 WORDS)

Acrylates↗

PubMed1995

The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs.

The angiotensin II (AII) type 1 receptor antagonists represent a new pharmacologic class of drugs that are specifically designed to displace AII from its type 1 receptor subtype. These drugs antagonize AII-induced biologic actions, including smooth-muscle contraction, sympathetic pressor mechanisms, and aldosterone release. Initial clinical trials suggest that these drugs are effective in the treatment of essential hypertension and hypertensive patients with intrinsic renal disease. Thus, they are the newest addition to the therapeutic armamentarium for the treatment of hypertensive diseases. We review the developmental history and pharmacology of the AII type 1 receptor antagonists. We specifically discuss the following factors: mechanism(s) of action; members under clinical investigation; effects on renal function, salt and water excretion, and plasma renin activity, plasma AII type 1, and plasma aldosterone concentrations; and efficacy and safety. Given the demonstrable benefits of AII type 1 receptor blockade, these drugs should achieve broad utility in the treatment of hypertensive diseases.

Acrylates↗

PubMed1995

Preparation and evaluation of sodium diclofenac controlled-release tablets. II. Dibasic calcium phosphate as a retardant in mixtures for direct compression.

The dissolution behaviour of a direct compression compact prepared with sodium diclofenac and dibasic calcium phosphate (DCP) in different weight ratios with or without Biosoluble polymer (acrylic-based resin) was investigated in distilled water and in a medium with changing pH. The results indicate that the amount of sodium diclofenac released from the compact was dependent on the amount of drug and DCP used in the compact, and was also controlled by the amount of Biosoluble polymer added. A chemical reaction forming diclofenac acid might occur on the surface of the sodium diclofenac compact during exposure to the acidic medium, which was confirmed by diffuse-reflectance spectroscopy. The tablet with a 1:2 weight ratio of sodium diclofenac to DCP exhibited a sustained-release behaviour, similar to commercial sustained-release products (Voltaren SR-100 and Grofenac Retard), but a lower release rate was found as compared to the commercial products. The dissolution behaviour of the study tablet and the commercial products was found to be dependent on the dissolution medium and the rotating speeds. Glass beads were added to the dissolution assembly to simulate the influence of food, and the enhanced friction between tablet and glass beads might result in a higher dissolution rate of the tablet and the commercial products.

Acrylates↗